PHILIP ATANMO: Open Payments
NPI 1376123018 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 16 payments from 4 companies in 2025. Trend: 2023 $509 · 2024 $14 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $225 |
| E.R. Squibb & Sons, L.L.C. | 2 | $82 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: Auvelity, COBENFY, INGREZZA, REXULTI.
Industry payments across FL — which companies pay providers there.
